Who have Headache with Rebif?


Summary

Headache is found among people who take Rebif, especially for people who are female, 40-49 old , have been taking the drug for 1 - 6 months, also take medication Ibuprofen, and have Multiple sclerosis . We study 45,926 people who have side effects while taking Rebif from FDA and social media. Among them, 2,607 have Headache. Find out below who they are, when they have Headache and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Rebif

Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. (latest outcomes from Rebif 46,188 users)

Headache

Headache (pain in head) has been reported by people with multiple sclerosis, rheumatoid arthritis, high blood pressure, depression, pain (latest reports from 305,936 Headache patients).

On Nov, 25, 2016

45,926 people reported to have side effects when taking Rebif.
Among them, 2,607 people (5.68%) have Headache


Number of reports submitted per year:

Could Rebif cause Headache?

Time on Rebif when people have Headache *:

  • < 1 month: 12.58 %
  • 1 - 6 months: 27.55 %
  • 6 - 12 months: 14.97 %
  • 1 - 2 years: 13.06 %
  • 2 - 5 years: 16.88 %
  • 5 - 10 years: 11.46 %
  • 10+ years: 3.5 %

Gender of people who have Headache when taking Rebif *:

  • female: 81.31 %
  • male: 18.69 %

Age of people who have Headache when taking Rebif *:

  • 0-1: 0.0 %
  • 2-9: 0.3 %
  • 10-19: 2.25 %
  • 20-29: 11.69 %
  • 30-39: 22.23 %
  • 40-49: 28.42 %
  • 50-59: 24.18 %
  • 60+: 10.94 %

Severity of Headache **:

  • least: 0.0 %
  • moderate: 50 %
  • severe: 50 %
  • most severe: 0.0 %

How people recovered from Headache **:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Top co-used drugs for these people *:

  • Ibuprofen (136 people, 5.22%)
  • Baclofen (133 people, 5.10%)
  • Ampyra (126 people, 4.83%)
  • Gabapentin (89 people, 3.41%)
  • Neurontin (80 people, 3.07%)

Forecasts by ePatient.care (We will alert you to new symptoms or undetected conditions when you take Rebif, learn more )

Potential co-existing conditions

  • Relapsing-Remitting Multiple Sclerosis (442 people, 16.95%)

Potential co-existing symptoms

  • Fatigue (432 people, 16.57%)
  • Injection Site Erythema (388 people, 14.88%)
  • Multiple Sclerosis Relapse (338 people, 12.97%)
  • Nausea (329 people, 12.62%)
  • Pain (315 people, 12.08%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Headache when taking Rebif?

Browse all side effects of Rebif

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Headache

Headache

Could your condition cause Headache

Headache

Related studies

Can you answer these questions?

More questions for: Rebif, Headache

You may be interested in these reviews

More reviews for: Rebif, Headache


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.